Previous 10 | Next 10 |
2023-05-10 05:30:00 ET Teladoc Health (NYSE: TDOC) and InMode (NASDAQ: INMD) both operate in high-growth industries. Teladoc is a leader in telemedicine. InMode specializes in selling devices in the minimally invasive and non-invasive aesthetics market. Both of these areas a...
2023-05-07 05:17:00 ET Are you looking for underappreciated growth stocks that can deliver big gains? Try starting your search in the rapidly growing industry for minimally invasive cosmetic procedures. The global market for noninvasive aesthetic treatments reached $61.2 billion in 2022...
2023-05-05 23:26:46 ET Summary InMode is a leading provider of innovative, energy-based, and minimally invasive aesthetic and medical treatment solutions. The company has seen explosive growth on both the top line and bottom line with revenues and EBITDA growing at a 46% and ...
2023-05-02 18:30:33 ET The stock of medical aesthetics tech company InMode (NASDAQ: INMD) wasn't looking very pretty on Tuesday. The company published its latest set of quarterly figures, and some investors found them sorely wanting. In consequence the share price took a 10% hit on ...
2023-05-02 12:30:33 ET Image source: The Motley Fool. InMode (NASDAQ: INMD) Q1 2023 Earnings Call May 02, 2023 , 8:30 a.m. ET Operator Continue reading For further details see: InMode (INMD) Q1 2023 Earnings Call Transcript
2023-05-02 11:17:09 ET Summary InMode is a pioneer, first mover and leader in the field of minimally-invasive treatment and it generates mouth-watering returns. InMode is set to exceed investors' expectations embedded in today's share price even if a recession hits. Demand will li...
2023-05-02 11:16:02 ET InMode Ltd. (INMD) Q1 2023 Earnings Conference Call May 2, 2023 8:30 AM ET Company Participants Miri Segal - Investor Relations, MS-IR LLC Moshe Mizrahy - Chairman and CEO Shakil Lakhani - President, North America Yair Malca - Chief Fin...
2023-05-02 07:03:28 ET InMode press release ( NASDAQ: INMD ): Q1 Non-GAAP EPS of $0.52. Revenue of $106.1M (+23.5% Y/Y). Shares -4.2% PM. 2023 Financial Outlook: Revenue between $525 million and $530 million (vs. consensus $530.71B); Non-GAAP gross ...
2023-04-12 08:56:34 ET Wednesday's U.S. equity trading will center around the government's latest inflation statistics, released before the opening bell. The futures spiked following the release of a softer CPI reading for March, with the headline figure rising 5% from last year . Here ...
2023-04-12 07:22:48 ET InMode ( NASDAQ: INMD ) announced on Wednesday its preliminary Q1 results. The company expects Q1 revenue in the range of $105.7M to $105.9M vs. consensus of $100.25M. Non-GAAP earnings per diluted share are estimated to come in th...
News, Short Squeeze, Breakout and More Instantly...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 106.5% to $1.38 on volume of 71,739,314 shares Renalytix plc (RNLX) rose 41.4% to $0.4269 on volume of 54,892,134 shares Maxeon Solar Technologies Ltd. (MAXN) fell 7.4% to $0.1951 on volume of 45...